MS drug trial for kids halted early: what we know
NCT ID NCT03368664
First seen Jan 08, 2026 · Last updated May 13, 2026 · Updated 23 times
Summary
This study aimed to see if the drug alemtuzumab could help children aged 10 to 17 with relapsing-remitting multiple sclerosis (MS) whose disease was still active despite other treatments. Researchers planned to measure brain lesions and safety, but the study was stopped early after enrolling only 16 participants. The results are limited, so it's unclear how well the drug works in this age group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational Site Number : 0400001
Vienna, 1090, Austria
-
Investigational Site Number : 2500001
Le Kremlin-Bicêtre, 94270, France
-
Investigational Site Number : 2500002
Strasbourg, 67091, France
-
Investigational Site Number : 3800001
Milan, 20132, Italy
-
Investigational Site Number : 3800004
Naples, Napoli, 80131, Italy
-
Investigational Site Number : 3800005
Cagliari, 09126, Italy
-
Investigational Site Number : 6160001
Warsaw, 04-730, Poland
-
Investigational Site Number : 6160002
Poznan, Greater Poland Voivodeship, 60-355, Poland
-
Investigational Site Number : 6160003
Lodz, Lódzkie, 93-338, Poland
-
Investigational Site Number : 6430001
Moscow, 119602, Russia
-
Investigational Site Number : 6430002
Saint Petersburg, 197110, Russia
-
Investigational Site Number : 6430004
Moscow, 129110, Russia
-
Investigational Site Number : 6430005
Saint Petersburg, 197022, Russia
-
Investigational Site Number : 7920001
Ankara, 06500, Turkey (Türkiye)
-
Investigational Site Number : 7920003
Istanbul, 34390, Turkey (Türkiye)
-
Investigational Site Number : 8260002
London, London, City of, WC1N 3JH, United Kingdom
Conditions
Explore the condition pages connected to this study.